Virbac stock holds steady after H1 2026 growth

Published on 09/02/2026 at 10:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Virbac stock is trading near EUR 336.75 as H1 2026 revenue rose 7.4 percent at constant exchange rates and full-year guidance was confirmed.

Virbac, FR0000031577, Illustration mit AI erstellt.

Virbac stock (FR0000031577) is trading at EUR 336.75, and the latest quoted close in the market consensus page is stamped September 1, 2026. The French animal-health group also reported H1 2026 revenue growth of 7.4 percent at constant exchange rates and kept its full-year outlook intact.

H1 growth still matters

The H1 2026 report points to a group that is still expanding sales while keeping the outlook steady into the second half of the year. Revenue rose 7.4 percent at constant exchange rates, a clean comparison with the prior-year period, while management reiterated its guidance after the interim numbers.

For investors, the key detail is the split between growth and guidance. A stock that can show 7.4 percent H1 growth and still confirm the full-year view usually keeps the focus on execution rather than on a reset.

Market price and peers

MarketScreener shows Virbac at EUR 336.75 with a flat 5-day change and a flat year-to-date move as of September 1, 2026. That leaves the share close to its recent range rather than in a dramatic rerating.

The same quote page also frames Virbac inside the veterinary drugs peer set, giving the stock a clear sector context on Euronext Paris. The number that stands out is simple: EUR 336.75, with no move in the 5-day or 1 January change columns.

Go deeper

Virbac H1 2026 details

The interim update combines the revenue trend with the unchanged full-year outlook, which is the main read-through for the stock.

Virbac coverage Investor Relations

Veterinary drugs backbone

Virbac is a veterinary medicines and animal-health group, and that product base is what gives the H1 2026 growth figure its weight. In this update, the business lens matters more than a pure chart move because the interim sales trend and the confirmed outlook are the two numbers investors can anchor to.

Stock at a glance

Virbac stock is quoted at EUR 336.75 as of September 1, 2026, according to the MarketScreener quote page. The flat 5-day and year-to-date columns suggest a market that is waiting for the next operating step rather than a sharp break in either direction.